← Back to All Filings

Boston Scientific EVP Allocates $519k to Stock in 401(k) Rebalance

Low SignificanceFebruary 27, 2026 at 5:32:31 PM EST

BOSTON SCIENTIFIC CORP

$BSX4CIK: 0000885725

Subscribe to track BSX

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Boston Scientific EVP Allocates $519k to Stock in 401(k) Rebalance

Company: BOSTON SCIENTIFIC CORP (BSX) Form: 4 | Filed: 2026/02/27 Significance: Low

Insider: Butcher Arthur C Title: EVP & Grp Pres, MedSurg & APAC | Relationship: Officer

Transaction: • Type: Buy (401k Rebalance) • Shares: 6,851 • Price: $75.76 • Value: $519,032 • Owned After: 20,205 (Indirect)

Key Insight: Executive increased indirect holdings via a discretionary 401(k) plan rebalancing. Transaction represents <0.001% of market cap.

Market Context: Routine retirement plan adjustment for a $110B market cap company.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: BOSTON SCIENTIFIC CORP (BSX)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: EVP Arthur Butcher acquired ~$519k in stock through a discretionary 401(k) plan rebalancing.
  • Market Impact: Neutral; transaction is small relative to market cap and administrative in nature.

Company Information

FieldValue
CompanyBOSTON SCIENTIFIC CORP
Ticker SymbolBSX
CIK0000885725
IndustrySurgical & Medical Instruments

Insider Information

FieldValue
NameButcher Arthur C
CIK0001678249
Title/PositionEVP & Grp Pres, MedSurg & APAC
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2026-02-19
Transaction CodeI (Discretionary Transaction in Benefit Plan)
Security TypeCommon Stock
Shares Involved6,851
Price Per Share$75.76
Total Value$519,032
Shares Owned After20,205 (Indirect via 401k)
Ownership TypeIndirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$519,032
% of Market Cap0.0005%
Shares Transacted6,851
% of Shares Outstanding0.0005%
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: With a market cap of $110.67 billion, a $519k transaction is immaterial to the broader stock price.
  • Ownership Concentration: The insider holds 20,205 shares indirectly and 55,792 shares directly. This transaction increases their specific 401(k) allocation significantly but represents a minor shift in total company ownership.
  • Transaction Significance: The transaction code 'I' indicates a rebalancing of a retirement plan, which is generally considered less indicative of market sentiment than an open market purchase ('P').

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction volume is negligible relative to the company's size and daily volume. The nature of the trade (401k rebalance) suggests personal financial planning rather than a directional market bet.

Volume & Sentiment

  • Expected Volume Impact: None.
  • Sentiment Indicator: Neutral.

Additional Context

Transaction Notes

  • Footnotes: The filing notes this acquisition was made pursuant to an election to rebalance holdings under the Company's 401(k) Retirement Savings Plan.
  • Total Holdings: In addition to the 20,205 indirect shares reported in this transaction line, the reporting person also holds 55,792 shares directly.
Topics:#BSX#BostonScientific#InsiderTrading#Form4#StockMarket#MedTech#Investing#FinancialEducation

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.